Recent News

• 06.11.2026 - Corporate Presentation
• 06.11.2026 - Topline Results from EB-101 Pivotal Phase 3 VIITAL™ Study
• 06.04.2026 - Corporate Presentation
• 06.04.2026 - Topline Results from EB-101 Pivotal Phase 3 VIITAL™ Study
• 06.01.2026 - Topline Results from EB-101 Pivotal Phase 3 VIITAL™ Study
• 06.01.2026 - Corporate Presentation
• 06.01.2026 - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 05.28.2026 - Corporate Presentation
• 05.28.2026 - Topline Results from EB-101 Pivotal Phase 3 VIITAL™ Study
• 05.26.2026 - Topline Results from EB-101 Pivotal Phase 3 VIITAL™ Study

Recent Filings

• 06.09.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.09.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.09.2026 - 144 Report of proposed sale of securities
• 06.09.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.09.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.08.2026 - 144 Report of proposed sale of securities
• 06.08.2026 - 144 Report of proposed sale of securities
• 06.08.2026 - 144 Report of proposed sale of securities
• 06.08.2026 - 144 Report of proposed sale of securities
• 06.04.2026 - 8-K Current report